Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 4
1990 1
1992 3
1993 1
1994 5
1995 8
1996 5
1997 4
1998 13
1999 9
2000 13
2001 10
2002 6
2003 8
2004 16
2005 9
2006 6
2007 6
2008 12
2009 9
2010 11
2011 5
2012 2
2013 9
2014 4
2015 9
2016 8
2017 3
2018 8
2019 9
2020 9
2021 8
2022 8
2023 4
2024 5
2025 5
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.
McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JFE, Emerson SS, Poulter NR, Engelmann MDM, Ripa MS, Hovingh GK, Brown-Frandsen K, Bain SC, Cavender MA, Gislum M, David JP, Buse JB; SOUL Study Group. McGuire DK, et al. Among authors: engelmann mdm. N Engl J Med. 2025 May 29;392(20):2001-2012. doi: 10.1056/NEJMoa2501006. Epub 2025 Mar 29. N Engl J Med. 2025. PMID: 40162642 Clinical Trial.
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial.
McGuire DK, Busui RP, Deanfield J, Inzucchi SE, Mann JFE, Marx N, Mulvagh SL, Poulter N, Engelmann MDM, Hovingh GK, Ripa MS, Gislum M, Brown-Frandsen K, Buse JB. McGuire DK, et al. Among authors: engelmann mdm. Diabetes Obes Metab. 2023 Jul;25(7):1932-1941. doi: 10.1111/dom.15058. Epub 2023 Apr 11. Diabetes Obes Metab. 2023. PMID: 36945734 Free article.
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
Marx N, Deanfield JE, Mann JFE, Arechavaleta R, Bain SC, Bajaj HS, Bayer Tanggaard K, Birkenfeld AL, Buse JB, Davicevic-Elez Z, Desouza C, Emerson SS, Engelmann MDM, Hovingh GK, Inzucchi SE, Jhund PS, Mulvagh SL, Pop-Busui R, Poulter NR, Rasmussen S, Tu ST, McGuire DK; SOUL Study Group. Marx N, et al. Among authors: engelmann mdm. Circulation. 2025 Jun 10;151(23):1639-1650. doi: 10.1161/CIRCULATIONAHA.125.074545. Epub 2025 Mar 29. Circulation. 2025. PMID: 40156843 Free PMC article. Clinical Trial.
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial.
Ridker PM, Devalaraja M, Baeres FMM, Engelmann MDM, Hovingh GK, Ivkovic M, Lo L, Kling D, Pergola P, Raj D, Libby P, Davidson M; RESCUE Investigators. Ridker PM, et al. Among authors: engelmann mdm. Lancet. 2021 May 29;397(10289):2060-2069. doi: 10.1016/S0140-6736(21)00520-1. Epub 2021 May 17. Lancet. 2021. PMID: 34015342 Clinical Trial.
Individualized Perioperative Blood Pressure Management in Patients Undergoing Major Abdominal Surgery: The IMPROVE-multi Randomized Clinical Trial.
Saugel B, Meidert AS, Brunkhorst FM, Bischoff R, Esser J, Mattis M, Naue P, Vogel K, Bergholz A, Flick M, Kröker A, Müller DX, Thomsen KK, Vokuhl C, Wegge M, Bratke S, Graeßner M, Jungwirth B, Schmid S, Grundmann CD, Wischermann JM, Kellner P, Steinhaus M, Grüßer L, Coldewey SM, Zacharowski K, Meybohm P, Habicher M, Zarbock A, Zitzmann A, Letz S, Neumann C, Larmann J, Renné T, Krause L, Vettorazzi E, Zapf A, Carlstedt A, Sessler DI, Kouz K; IMPROVE-multi Trial Group. Saugel B, et al. JAMA. 2025 Dec 2;334(21):1893-1904. doi: 10.1001/jama.2025.17235. JAMA. 2025. PMID: 41076588 Clinical Trial.
Recognizing Others: Rodent's Social Memories.
Camats Perna J, Engelmann M. Camats Perna J, et al. Among authors: engelmann m. Curr Top Behav Neurosci. 2017;30:25-45. doi: 10.1007/7854_2015_413. Curr Top Behav Neurosci. 2017. PMID: 26643999 Review.
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial: Interleukin-6 Inhibition and Atherosclerotic Event Rate Reduction.
Ridker PM, Baeres FMM, Hveplund A, Engelmann MMD, Hovingh GK, Lincoff AM, Marx N, Navar AM, Sattar N, Tuttle K, Perkovic V. Ridker PM, et al. Among authors: engelmann mmd. JAMA Cardiol. 2026 Jan 1;11(1):89-97. doi: 10.1001/jamacardio.2025.4491. JAMA Cardiol. 2026. PMID: 41369941 Clinical Trial.
A State of Natriuretic Peptide Deficiency.
Nyberg M, Terzic D, Ludvigsen TP, Mark PD, Michaelsen NB, Abildstrøm SZ, Engelmann M, Richards AM, Goetze JP. Nyberg M, et al. Among authors: engelmann m. Endocr Rev. 2023 May 8;44(3):379-392. doi: 10.1210/endrev/bnac029. Endocr Rev. 2023. PMID: 36346821 Free PMC article.
Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial.
Mann JFE, Marx N, Deanfield JE, Emerson SS, Inzucchi SE, McGuire DK, Mulvagh SL, Pop-Busui R, Poulter NR, Engelmann MDM, Hovingh GK, Belmar N, Idorn T, Jeppesen OK, Birkenfeld AL, Amod A, Mankovsky B, Desouza C, Gorgojo-Martinez JJ, Arechavaleta R, Tu ST, Buse JB; SOUL Study Group*. Mann JFE, et al. Among authors: engelmann mdm. Diabetes Care. 2026 Feb 1;49(2):257-265. doi: 10.2337/dc25-1080. Diabetes Care. 2026. PMID: 41380027 Free PMC article. Clinical Trial.
Vasopressin and post-traumatic stress disorder.
Sipos E, Török B, Barna I, Engelmann M, Zelena D. Sipos E, et al. Among authors: engelmann m. Stress. 2020 Nov;23(6):732-745. doi: 10.1080/10253890.2020.1826430. Epub 2020 Oct 12. Stress. 2020. PMID: 33043781 Free article.
242 results